BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Synthetic Biologics, Inc. (SYN) To Present At The 27th Annual ROTH Conference 3/3/2015 10:24:11 AM
Synthetic Biologics, Inc. (SYN) Announces Two Poster Presentations Of Novel Monoclonal Antibody Combination For Treatment Of Whooping Cough (Pertussis) At ECCMID 2015 3/2/2015 8:33:06 AM
Synthetic Biologics, Inc. (SYN) Announces Poster Presentation Of C-IBS Candidate Therapy Data At Digestive Disease Week 2015 2/17/2015 11:44:12 AM
Synthetic Biologics, Inc. (SYN) Announces Positive Topline Results From Phase 1b Trial Of SYN-004 To Protect The Microbiome And Prevent C. Difficile Infection 2/10/2015 7:17:57 AM
Synthetic Biologics, Inc. (SYN) To Present At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 11:50:08 AM
Synthetic Biologics, Inc. (SYN) To Present At The Biotech Showcase™ 2015 Conference 1/7/2015 8:44:43 AM
Synthetic Biologics, Inc. (SYN) Announces First Patient Dosed In Phase 1b Clinical Trial Of SYN-004 For The Prevention Of C. Difficile Infection 12/30/2014 7:25:07 AM
Synthetic Biologics, Inc. (SYN) Announces Positive Topline Results From Phase 1a Trial Of SYN-004 For The Prevention Of C. Difficile Infection 12/22/2014 7:46:01 AM
Synthetic Biologics, Inc. (SYN) Safe-To-Proceed Under IND To Initiate Clinical Trials Of SYN-004 For The Prevention C. Difficile Infection 11/24/2014 9:47:31 AM
Synthetic Biologics, Inc. (SYN) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014 8:04:40 AM
12345678910...